Find the Perfect Plan for Your Investment Journey
A
Latest price
52 Week Range
ZAR10.58K - ZAR25.30K
Next Earnings Date
Sep 01 2025 (Estimate)
Next Earnings Date
Sep 01 2025 (Est.)
Latest price
Market Cap | ZAR52.77B |
EV | ZAR81.44B |
Shares Outstanding | 444.21M |
Beta | 0.58 |
Analyst Rating | HOLD |
Analyst Target Price | ZAR157.26 |
P/E 2025E | 7.65x |
P/Revenue 2025E | 1.11x |
Revenue | 5.80% |
EPS | 4.40% |
Operating Cash Flow | -3.00% |
Free Cash Flow | -41.20% |
Revenue | 5.30% |
EPS | 8.50% |
Operating Cash Flow | 21.00% |
Free Cash Flow | 107.40% |
Gross Margin 2025E | 49.60% |
Net Profit Margin 2025E | 8.69% |
ROE 2025E | 6.88% |
ROCE 2024 | 5.15% |
DPS 2025E | ZAR3.53 |
Payout Ratio 2025E | 24.13% |
Div. Yield 2025E | 0.03% |
DPS Last 3Y CAGR | 11.10% |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Aspen Pharmacare Holdings Limited
APN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Saad, Stephen
Employees
9,109
Website
www.aspenpharma.comIPO Date
2000-01-04
Headquarters
Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge, Durban, KwaZulu-Natal South Africa
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved